Low‐pass whole genome sequencing as a cost‐effective alternative to chromosomal microarray analysis for low‐ and middle‐income countries
American Journal of Medical Genetics Part A · 2024
DOI: 10.1002/ajmg.a.63802 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Patricia C Mazzonetto und 29 weiteren Autor:innen. Beteiligte Einrichtung: The Human Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of São Paulo, S…. Hauptthemen laut MEDLINE: DNA Copy Number Variations, Whole Genome Sequencing. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: FAPESP, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Low‐pass whole genome sequencing (LP‐WGS) has been applied as alternative method to detect copy number variants (CNVs) in the clinical setting. Compared with chromosomal microarray analysis (CMA), the sequencing‐based approach provides a similar resolution of CNV detection at a lower cost. In this study, we assessed the efficiency and reliability of LP‐WGS as a more affordable alternative to CMA. A total of 1363 patients with unexplained neurodevelopmental delay/intellectual disability, autism spectrum disorders, and/or multiple congenital anomalies were enrolled. Those patients were referred from 15 nonprofit organizations and university centers located in different states in Brazil. The analysis of LP‐WGS at 1x coverage (>50kb) revealed a positive testing result in 22% of the cases (304/1363), in which 219 and 85 correspond to pathogenic/likely pathogenic (P/LP) CNVs and variants of uncertain significance (VUS), respectively. The 16% (219/1363) diagnostic yield observed in our cohort is comparable to the 15%–20% reported for CMA in the literature. The use of commercial software, as demonstrated in this study, simplifies the implementation of the test in clinical settings. Particularly for countries like Brazil, where the cost of CMA presents a substantial barrier to most of the population, LP‐WGS emerges as a cost‐effective alternative for investigating copy number changes in cytogenetics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Human Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of São Paulo, São Paulo, Brazil.
- Diagnósticos da América S.A., DASA, São Paulo, Brazil.
- Casa dos Raros - House of Rares, Centro de Atenção Integral e Treinamento em Doenças Raras, Porto Alegre, Brazil.
- INAGEMP, Instituto Nacional de Genética Médica Populacional, Porto Alegre, Brazil.
- Instituto da Criança, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
- Faculdade de Medicina, Universidade de Brasília, Brasília, Brazil.
ORCID-Profile: Darine Villela, Mariluce Riegel-Giugliani, Juliana F Mazzeu, Nancy M Kokitsu-Nakata, Társis Paiva Vieira, Carlos Eduardo Steiner
Förderung
- FAPESP
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Mazzonetto, P. C., Villela, D., Krepischi, A. C. V., Pierry, P. M., Bonaldi, A., Almeida, L. G. D., Paula, M. G., Bürger, M. C., de Oliveira, A. G., Fonseca, G. G. G., Giugliani, R., Riegel-Giugliani, M., Bertola, D., Yamamoto, G. L., Passos-Bueno, M. R., Campos, G. D. S., Machado, A. C. D., Mazzeu, J. F., Perrone, E., …, & Rosenberg, C. (2024). Low‐pass whole genome sequencing as a cost‐effective alternative to chromosomal microarray analysis for low‐ and middle‐income countries. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63802
Vancouver
Mazzonetto PC, Villela D, Krepischi ACV, Pierry PM, Bonaldi A, Almeida LGD, et al. Low‐pass whole genome sequencing as a cost‐effective alternative to chromosomal microarray analysis for low‐ and middle‐income countries. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63802
BibTeX
@article{Mazzonetto2024,
author = {Mazzonetto, Patricia C and Villela, Darine and Krepischi, Ana C V and Pierry, Paulo M and Bonaldi, Adriano and Almeida, Luiz Gustavo D and Paula, Marcelo G and Bürger, Matheus Carvalho and de Oliveira, Ana Gabriela and Fonseca, Gustavo G G and Giugliani, Roberto and Riegel-Giugliani, Mariluce and Bertola, Débora and Yamamoto, Guilherme Lopes and Passos-Bueno, Maria Rita and Campos, Gabriele da Silva and Machado, Ana Claudia Dantas and Mazzeu, Juliana F and Perrone, Eduardo and Zechi-Ceide, Roseli M and Kokitsu-Nakata, Nancy M and Vieira, Társis Paiva and Steiner, Carlos Eduardo and Gil-da-Silva-Lopes, Vera Lúcia and Vieira, Daniela Koeller Rodrigues and Boy, Raquel and de Pina-Neto, João Monteiro and Scapulatempo-Neto, Cristovam and Milanezi, Fernanda and Rosenberg, Carla},
title = {Low‐pass whole genome sequencing as a cost‐effective alternative to chromosomal microarray analysis for low‐ and middle‐income countries},
journal = {American Journal of Medical Genetics Part A},
year = {2024},
doi = {10.1002/ajmg.a.63802}
}
EUVIMED